Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Chung Ju

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Psychopharmacology (Oxford, England)|November 12, 2025
Antidepressant initiation and the risk of treatment-emergent mania in children and adolescents with depression: A real-world cohort studyYu Chang, Ming-Hong Hsieh, Po-Chung Ju, et al.
Journal of Affective Disorders|March 31, 2026
Early change in daily step counts after antidepressant initiation among adults with depression: A within-person interrupted time series studyYu Chang, Ming-Hong Hsieh, Po-Chung Ju, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 20, 2026
Residual genetic connectivity beyond shared liability in 14 psychiatric disordersYu Chang, Ming-Hong Hsieh, Po-Chung Ju, et al.
Diabetes, Obesity & Metabolism|September 29, 2025
Risk of depression with GLP-1 receptor agonists use in overweight or obese adults with type 2 diabetes: A new-user, active-comparator cohort studyYu Chang, Ming-Hong Hsieh, Po-Chung Ju, et al.
Diabetes, Obesity & Metabolism|May 28, 2026
Risk of Psychiatric Worsening With GLP-1 Receptor Agonist Use in Patients With Type 2 Diabetes and Treated DepressionYu Chang, Ming-Hong Hsieh, Po-Chung Ju, et al.
European Child & Adolescent Psychiatry|April 10, 2026
Dose-response, net clinical benefit and optimal dose ranges of stimulants in children and adolescents with ADHD: a network meta-analysisYu Chang, Po-Chung Ju, Ming-Hong Hsieh, et al.
Journal of Medical Systems|May 11, 2026
Clinical Plausibility in Large Language Model Robustness Testing for Medicine: A Scoping ReviewYu Chang, Ming-Hong Hsieh, Po-Chung Ju, et al.
Psychiatry Investigation|November 3, 2022
Spousal Concordance and Cross-Disorder Concordance of Mental Disorders: A Nationwide Cohort StudyMing-Hong Hsieh, Po-Chung Ju, Jeng-Yuan Chiou, et al.
Environmental Toxicology|October 2, 2023
HO-3867, a curcumin analog, elicits cell apoptosis and p38-mediated caspase activation in hepatocellular carcinomaKuan-Chun Hsueh, Po-Chung Ju, Yi-Hsien Hsieh, et al.
Psychiatry Research|October 19, 2015
Effects of antidepressant treatment on total antioxidant capacity and free radical levels in patients with major depressive disorderCheng-Chen Chang, Chun-Te Lee, Tsuo-Hung Lan, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Psychopharmacology (Oxford, England)|November 12, 2025
Antidepressant initiation and the risk of treatment-emergent mania in children and adolescents with depression: A real-world cohort studyYu Chang, Ming-Hong Hsieh, Po-Chung Ju, et al.
Journal of Affective Disorders|March 31, 2026
Early change in daily step counts after antidepressant initiation among adults with depression: A within-person interrupted time series studyYu Chang, Ming-Hong Hsieh, Po-Chung Ju, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 20, 2026
Residual genetic connectivity beyond shared liability in 14 psychiatric disordersYu Chang, Ming-Hong Hsieh, Po-Chung Ju, et al.
Diabetes, Obesity & Metabolism|September 29, 2025
Risk of depression with GLP-1 receptor agonists use in overweight or obese adults with type 2 diabetes: A new-user, active-comparator cohort studyYu Chang, Ming-Hong Hsieh, Po-Chung Ju, et al.
Diabetes, Obesity & Metabolism|May 28, 2026
Risk of Psychiatric Worsening With GLP-1 Receptor Agonist Use in Patients With Type 2 Diabetes and Treated DepressionYu Chang, Ming-Hong Hsieh, Po-Chung Ju, et al.
European Child & Adolescent Psychiatry|April 10, 2026
Dose-response, net clinical benefit and optimal dose ranges of stimulants in children and adolescents with ADHD: a network meta-analysisYu Chang, Po-Chung Ju, Ming-Hong Hsieh, et al.
Journal of Medical Systems|May 11, 2026
Clinical Plausibility in Large Language Model Robustness Testing for Medicine: A Scoping ReviewYu Chang, Ming-Hong Hsieh, Po-Chung Ju, et al.
Psychiatry Investigation|November 3, 2022
Spousal Concordance and Cross-Disorder Concordance of Mental Disorders: A Nationwide Cohort StudyMing-Hong Hsieh, Po-Chung Ju, Jeng-Yuan Chiou, et al.
Environmental Toxicology|October 2, 2023
HO-3867, a curcumin analog, elicits cell apoptosis and p38-mediated caspase activation in hepatocellular carcinomaKuan-Chun Hsueh, Po-Chung Ju, Yi-Hsien Hsieh, et al.
Psychiatry Research|October 19, 2015
Effects of antidepressant treatment on total antioxidant capacity and free radical levels in patients with major depressive disorderCheng-Chen Chang, Chun-Te Lee, Tsuo-Hung Lan, et al.
Pageof 3